Perioperative Three Dimensional Right Ventricular Function

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02820727

Enrollment

Registered

2016-07-01

Start date

2015-10-31

Completion date

2016-11-30

Last updated

2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Diseases

Brief summary

This study addresses the influence of anesthesia induction, ventilation and influence of cardiac surgical procedures and cardio-pulmonary-bypass on right ventricular function. Influence on patient outcome is also studied. Three dimensional echocardiography is applied.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 99 Years

Healthy volunteers

Inclusion criteria

* informed consent given * cardiac surgical procedure * left sided cardiac surgery or bypass surgery, ascending aortic surgery, assist device implantation

Exclusion criteria

* pregnant patients * contraindication for transesophageal echocardiography

Design outcomes

Primary

Measure	Time frame	Description
Time on Intensive Care Unit (ICU)	up to 60 days	Duration of ICU stay

Secondary

Measure	Time frame	Description
Organ failure during ICU stay	up to 60 days	Early organ failure (Lab tests: Creatinine, Bilirubin, Lactate, Thromboplastin Time)
Time to hospital discharge	up to 120 days	Hospital Outcome
Catecholamine dosages	up to 24 hours	after anesthesia induction, end of surgery, 12h and 24h after intensive care unit (ICU) admission
Catecholamine free days	up to 60 days	Catecholamine free days on ICU
Hours on mechanical ventilation	up to 1440 hours	Duration of mechanical ventilation

Countries

Germany

Outcome results